🇺🇸 FDA
Patent

US 9683263

Detection and treatment of irritable bowel syndrome

granted A61KA61K31/7088A61K31/711

Quick answer

US patent 9683263 (Detection and treatment of irritable bowel syndrome) held by The United States of America, as represented by the Secretary, Department of Health and Human Services expires Mon Jun 15 2037 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The United States of America, as represented by the Secretary, Department of Health and Human Services
Grant date
Tue Jun 20 2017 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jun 15 2037 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
24
CPC classes
A61K, A61K31/7088, A61K31/711